Darbar D - Search Results

1

Symptomatic burden as an endpoint to evaluate interventions in patients with atrial fibrillation.

Darbar D, Roden DM. Darbar D, et al. Heart Rhythm. 2005 May;2(5):544-9. doi: 10.1016/j.hrthm.2005.01.028. Heart Rhythm. 2005. PMID: 15840484

2

Arrhythmogenic right ventricular cardiomyopathy due to a novel plakophilin 2 mutation: wide spectrum of disease in mutation carriers within a family.

Kannankeril PJ, Bhuiyan ZA, Darbar D, Mannens MM, Wilde AA, Roden DM. Kannankeril PJ, et al. Among authors: darbar d. Heart Rhythm. 2006 Aug;3(8):939-44. doi: 10.1016/j.hrthm.2006.04.028. Epub 2006 May 3. Heart Rhythm. 2006. PMID: 16876743

3

A rate-independent method of assessing QT-RR slope following conversion of atrial fibrillation.

Darbar D, Hardin B, Harris P, Roden DM. Darbar D, et al. J Cardiovasc Electrophysiol. 2007 Jun;18(6):636-41. doi: 10.1111/j.1540-8167.2007.00817.x. Epub 2007 May 3. J Cardiovasc Electrophysiol. 2007. PMID: 17488270 Clinical Trial.

4

Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.

Darbar D, Motsinger AA, Ritchie MD, Gainer JV, Roden DM. Darbar D, et al. Heart Rhythm. 2007 Jun;4(6):743-9. doi: 10.1016/j.hrthm.2007.02.006. Epub 2007 Feb 9. Heart Rhythm. 2007. PMID: 17556195 Free PMC article.

5

Future of antiarrhythmic drugs.

Darbar D, Roden DM. Darbar D, et al. Curr Opin Cardiol. 2006 Jul;21(4):361-7. doi: 10.1097/01.hco.0000231407.61683.05. Curr Opin Cardiol. 2006. PMID: 16755206 Review.

6

Pharmacogenetics of antiarrhythmic therapy.

Darbar D, Roden DM. Darbar D, et al. Expert Opin Pharmacother. 2006 Aug;7(12):1583-90. doi: 10.1517/14656566.7.12.1583. Expert Opin Pharmacother. 2006. PMID: 16872261 Review.

7

On the relationship among QT interval, atrial fibrillation, and torsade de pointes.

Roden DM, Kannankeril P, Darbar D. Roden DM, et al. Among authors: darbar d. Europace. 2007 Sep;9 Suppl 4(Suppl 4):iv1-3. doi: 10.1093/europace/eum165. Europace. 2007. PMID: 17766319 Free PMC article. No abstract available.

8

Persistent atrial fibrillation is associated with reduced risk of torsades de pointes in patients with drug-induced long QT syndrome.

Darbar D, Kimbrough J, Jawaid A, McCray R, Ritchie MD, Roden DM. Darbar D, et al. J Am Coll Cardiol. 2008 Feb 26;51(8):836-42. doi: 10.1016/j.jacc.2007.09.066. J Am Coll Cardiol. 2008. PMID: 18294569 Free PMC article.

9

Exaggerated QT prolongation after cardioversion of atrial fibrillation.

Choy AM, Darbar D, Dell'Orto S, Roden DM. Choy AM, et al. Among authors: darbar d. J Am Coll Cardiol. 1999 Aug;34(2):396-401. doi: 10.1016/s0735-1097(99)00226-0. J Am Coll Cardiol. 1999. PMID: 10440151 Free article.

10

Unmasking of brugada syndrome by lithium.

Darbar D, Yang T, Churchwell K, Wilde AA, Roden DM. Darbar D, et al. Circulation. 2005 Sep 13;112(11):1527-31. doi: 10.1161/CIRCULATIONAHA.105.548487. Epub 2005 Sep 6. Circulation. 2005. PMID: 16144991 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

258 results

Search Page

Filters